Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond by Charlotte Schubert on February 8, 2022August 21, 2022 at 10:46 pm When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More